Yeast Display VHH Screening Service

Overview

Yeast surface display enables quantitative screening of VHH candidates by linking displayed binders with their encoding sequences. At NBbiolab, our Yeast Display VHH Screening Service combines high-diversity VHH libraries with magnetic enrichment and fluorescence-activated cell sorting to progressively identify candidates with the desired binding characteristics.

Screening strategies can be tailored according to project objectives, including binding strength, specificity, epitope competition, and other defined selection criteria. Enriched VHH populations can be further analyzed by monoclonal sequencing or NGS, followed by recombinant expression and binding validation of selected candidates.

The service can support projects starting from custom immune VHH libraries or suitable existing libraries and can connect with downstream affinity maturation, humanization, and antibody engineering. This creates an integrated path from Yeast Library Screening to validated candidates within a broader VHH Binder Discovery workflow.

When to Use Yeast Display for Nanobody Discovery

Yeast display is particularly advantageous for: Discovery of high-affinity VHH binders
Screening against soluble protein antigens
Quantitative affinity-based selection
Affinity maturation of existing nanobody candidates
Screening libraries with precise control of binding conditions

Yeast Display VHH Screening Capabilities

NBbiolab provides an integrated Yeast Display VHH Screening Service for the identification and selection of target-specific VHH binders. Based on our Yeast Surface Display Platform , the screening strategy combines high-diversity VHH libraries, magnetic enrichment, multi-parameter FACS sorting, and sequence analysis to progressively enrich candidates with the desired binding profile.

High-Diversity VHH Library Screening

High-quality yeast display VHH libraries with capacities exceeding 1 × 10⁸ clones provide broad sequence coverage for binder discovery. Our Yeast Library Screening Service is designed to efficiently identify target-binding VHH candidates while maintaining library diversity throughout the enrichment process.

MACS Enrichment and Multi-Parameter FACS Selection

Magnetic-activated cell sorting (MACS) can be used for initial enrichment, followed by multi-color fluorescence-activated cell sorting (FACS) for higher-resolution selection. This combination enables progressive enrichment of VHH populations according to defined screening criteria while reducing non-specific binders.

Affinity, Specificity and Epitope-Oriented Screening

FACS-based yeast display enables quantitative and tunable selection based on binding signals. Screening strategies can be adapted for affinity-based selection, specificity assessment, and epitope competition, helping distinguish VHH candidates with different binding characteristics during the discovery process.

Sequence Analysis and Binder Identification

Enriched VHH populations can be evaluated using monoclonal sequencing or NGS-based analysis. Selected candidates can then proceed to recombinant expression and binding validation, connecting library screening with a complete VHH Binder Discovery Service and providing qualified candidates for downstream development.

Our Yeast Display VHH Discovery Workflow

Deliverables

Clients will receive

High-affinity VHH binder sequences
Clone information and sequence alignment
Binding validation data
Expression-ready constructs
Comprehensive project report

VHH Library & Screening Strategy

The quality of VHH binder discovery depends not only on library diversity, but also on selecting the right library source and screening strategy for the target. At NBbiolab, we tailor each Yeast Library Screening Service according to the antigen format, discovery objective, project timeline, and required binder properties. Projects can begin with an immune VHH library, an existing premade library, or another display strategy when appropriate.

Immune VHH Library for Target-Specific Discovery

For projects that require a target-specific immune response, VHH libraries can be generated from immunized camelids and subsequently transferred into the yeast display workflow for binder screening. This route is suitable when the discovery program starts from a new antigen and requires a dedicated library generated specifically for that target. If an immune library needs to be established first, explore our Animal Immunization Service .

Premade Library Screening for Faster Project Initiation

When animal immunization and custom immune library construction are not required, screening can begin from an available premade VHH library. This approach can shorten the early discovery stage and is particularly useful for rapid target evaluation and exploratory binder discovery. Detailed library options and screening routes are available through our Premade Library Screening service.

Yeast Display for High-Resolution VHH Selection

Yeast display is selected when quantitative, FACS-based discrimination between VHH candidates is important. Following initial enrichment, screening conditions can be progressively adjusted to select binders according to binding strength, specificity, or other defined selection criteria. This makes the platform particularly useful for projects requiring controlled selection pressure and detailed comparison of candidate populations.

When Phage Display May Be Considered

Yeast display is not the only option for every VHH discovery project. Where very large library diversity and broad initial binder enrichment are the primary priorities, phage display may also be considered. NBbiolab supports both technologies, allowing the screening route to be selected according to the target and project objective rather than applying the same workflow to every program. Learn more about our Phage Display Nanobody Discovery Service .

A Screening Strategy Built Around the Discovery Goal

Rather than treating library screening as a fixed process, NBbiolab evaluates the starting library, antigen characteristics, required binder profile, and downstream development plan before defining the screening strategy. This integrated approach connects VHH library design and enrichment with candidate identification and supports a more targeted VHH Binder Discovery Service.

From VHH Screening to Validated Binder

Identifying enriched clones is only one part of a successful VHH Binder Discovery Service. At NBbiolab, selected VHH candidates can progress from sequence identification to recombinant production, binding validation, and further engineering, helping clients move from yeast display screening toward candidates suitable for downstream research and development.

1. Candidate Sequence Identification

Following MACS and FACS enrichment, selected VHH populations are analyzed to identify promising binder sequences. Clone information, sequence alignment, monoclonal sequencing, or NGS-based analysis can be used to evaluate enriched candidates and support the selection of representative VHHs for further validation.

2. Recombinant VHH Production

Selected sequences can be transferred from the screening platform into recombinant expression formats for candidate production. Purified VHH or VHH-Fc proteins can then be prepared for downstream binding and characterization studies, allowing screening hits to be evaluated outside the yeast display system.

3. Binding and Candidate Validation

Recombinant candidates can be evaluated for binding performance and blocking characteristics according to the project requirements. This validation step helps confirm that VHHs identified during Yeast Display VHH Screening retain the expected target-binding properties after recombinant expression.

4. Affinity Optimization for Promising VHH Candidates

When a selected binder requires further affinity improvement, promising candidates can enter NBbiolab's Antibody Affinity Maturation Service . The platform combines rational library design, mutagenesis strategies, and quantitative yeast display screening to identify affinity-enhanced antibody and nanobody variants while considering specificity, stability, expression, and developability.

5. Humanization for Therapeutic Development

For therapeutic VHH programs, selected camelid-derived binders may also proceed to Nanobody Humanization Service . NBbiolab integrates sequence analysis, structural modeling, immunogenicity assessment, and rational engineering to generate humanized VHH candidates while aiming to preserve important binding and developability properties.

An Integrated Path from Screening Hit to Development Candidate

By connecting yeast display library screening, sequence analysis, recombinant production, validation, and optional engineering within one workflow, NBbiolab helps reduce handoffs between separate service providers. Clients can move promising VHH binders directly into affinity maturation, humanization, or additional characterization according to the next stage of the development program.

Optional downstream services

Nanobody Humanization Affinity maturation Functional Characterization

Typical Project Timeline

Package	Service Step	Deliverables	Timeline
Basic	Yeast VHH Library Construction	High-quality yeast VHH display library	~4 weeks
Basic	Yeast Display Screening	Target-binding VHH sequences and screening report	4–6 weeks
Basic	Candidate Production	Purified VHH or VHH-Fc antibodies	~2 weeks
Basic	Characterization	Binding affinity and blocking profile	1–2 weeks

* The timeline above covers the yeast display library construction <br> and screening stages of nanobody discovery. If camelid immunization is required, an additional 6–8 weeks may be needed.

Advantages of Yeast Display Screening

Compared with other discovery technologies, yeast display provides several advantages:
Quantitative affinity-based selection using FACS
Reduced false-positive rates
High display levels (10⁴–10⁵ copies per cell)
Real-time monitoring of binding signals
Direct genotype-phenotype linkage
Eukaryotic expression system closer to mammalian folding

Why Choose Our Yeast Display VHH Discovery Service

Extensive Experience

Our team has extensive experience in nanobody discovery and yeast display screening across a wide range of targets.

High-Quality VHH Libraries

We construct high-diversity libraries with capacities exceeding 1 × 10⁸ clones, ensuring broad coverage of potential binders.

Advanced FACS Screening

Multi-color flow cytometry enables precise affinity-based selection under controlled screening conditions.

Low False Positive Rate

The combination of MACS enrichment and FACS sorting significantly reduces non-specific binders.

FAQs

How does yeast display support nanobody discovery?

Yeast display technology enables surface expression of individual nanobody sequences on yeast cells, supporting high-throughput screening of billions of variants for target-specific binding. Coupled with fluorescence-activated cell sorting (FACS), this platform enables rapid isolation of high-affinity nanobody candidates, with significantly shortened R&D timelines relative to conventional discovery approaches.

Can you generate nanobodies against challenging targets like membrane proteins and small molecules?

Our yeast display platform is fully compatible with challenging targets, including multi-pass transmembrane proteins and small-molecule haptens. Customized library design and tailored screening workflows enable robust generation of high-quality binders, even for targets with low immunogenicity or complex structural features, with markedly improved discovery success rates.

How is yeast display different from phage display for nanobody discovery?

Key differences:

Yeast display: high-resolution affinity sorting (FACS-based)

Phage display: large-scale library enrichment

Yeast display: better for affinity maturation and fine selection

Phage display: better for initial hit discovery

When should I choose yeast display for my nanobody project?

Yeast display is particularly suitable when:

High-affinity binders are required

Fine affinity discrimination is important

Target is a soluble protein or well-characterized antigen

Affinity maturation is needed

Precise selection pressure control is required

It is also highly effective for downstream functional antibody development.

Can yeast display be used for membrane protein targets?

Yes, but typically with recombinant extracellular domains or engineered antigen formats.
Yeast display is more suitable for purified recombinant protein screening and well-folded, structurally stable antigens. It is generally less ideal for direct cell-based selection due to larger cell size and higher background in cell-sorting assays, which can reduce specificity resolution.

What library size can yeast display achieve?

Our Yeast display libraries can reach 10⁸ range (garanteed quality).

While smaller than phage display libraries, yeast display compensates with functional screening precision and affinity-based selection power.

Can yeast display be used for affinity maturation?

Yes. Yeast display is one of the most commonly used platforms for

affinity maturation and binding optimization under controlled conditions.

It allows fine discrimination between closely related variants.